Evonik operates one of the industry’s most robust high-potency and controlled substance manufacturing platforms, anchored at our Tippecanoe site in Indiana, USA. With over 860 m³ of reactor capacity—including 170 m³ dedicated to HPAPI—we offer end-to-end scalability under stringent containment and compliance standards. Our Dossenheim, Germany site extends our capabilities to include intermediates and APIs under regulatory frameworks for scheduled controlled substances, ensuring global access and secure supply.
Typical Applications
- Manufacturing of High Potent and Cancer APIs
- Manufacturing of Controlled Substances
- End to end CDMO services
Benefits at a glance
- Global scale, western manufacturing footprint
- Comprehensive support for all project phases from clinical development to commercial
- Comprehensive management system with internal toxicology and industrial hygiene specialists